Merck and BGI have established a collaboration to focus on the discovery and development of biomarkers and genomic technologies. The two companies will work together to identify and characterize biomarkers with an emphasis on drug discovery, development and diagnostics applications across a wide range of therapeutic areas. Under the agreement each company can propose projects under the collaboration. Both Merck and BGI will provide resources, expertise, samples and other research material as nee...